.
ADTX financial statements
* Numbers in thousands
Year |
2020 | TTM |
---|---|---|
Capitalization * |
25 747 | 2 588 |
EV * |
16 225 | 16 225 |
Stock price $ |
3.73 | 0.3749 |
Number of shares * |
6 903 | 6 903 |
EPS |
-1,33 | -1,33 |
Revenue * |
0 | 0 |
Net income * |
-9 149 | -9 149 |
Operating profit * |
-8 872 | -8 872 |
Total liabilities * |
2 085 | 2 085 |
Net debt * |
-8 664 | -8 664 |
Total assets * |
13 097 | 13 097 |
Equity * |
11 011 | 11 011 |
Cash and investments * |
10 501 | 10 501 |
Over the past 10 years, the maximum capitalization of ADiTx Therapeutics, Inc. is 25 747, the minimum is 25 747. Maximum net income 0, Minimum net income -9 149. The maximum price of ADTX shares is 3.73, the minimum price is 3.73.
.
ADTX valuation
Year |
2020 | TTM |
---|---|---|
P/E |
-2,81 | -0,28 |
P/B |
2,34 | 0,24 |
P/S |
0,00 | 0,00 |
E/P |
-36% | -354% |
P/FCF |
-3,48 | -0,35 |
.
ADTX profitability
Year |
2020 | TTM |
---|---|---|
ROE |
-83% | |
ROA |
-72% | |
ROIC |
-75% |